Targeting Epigenome As An Innovative Pharmacological Strategy For Castration-resistant Prostate Cancer

ISSN： 2212-697X

Source： Clinical Cancer Drugs, Vol.3, Iss.1, 2016-05, pp. : 23-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Epigenome As An Innovative Pharmacological Strategy For Castration-resistant Prostate Cancer

Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-03 ,pp. : 23-35

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Bone Microenvironment in Metastatic Castration-Resistant Prostate Cancer

Current Drug Targets, Vol. 17, Iss. 3, 2016-03 ,pp. : 1-13

Bentham Science Publishers

Access to resources Recommend Favorite

Castration-resistant Prostate Cancer: The Targeting of Bone Microenvironment-related Survival Factors For Prostate Cancer Cells

Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-05 ,pp. : 16-22

Bentham Science Publishers

Access to resources Recommend Favorite

Cholesterol as a Potential Target for Castration-Resistant Prostate Cancer

By Twiddy Alexis Leon Carlos Wasan Kishor

Pharmaceutical Research, Vol. 28, Iss. 3, 2011-03 ,pp. : 423-437

Springer Publishing Company

Access to resources Recommend Favorite

Sipuleucel-T: In Metastatic Castration-Resistant Prostate Cancer

By Plosker Greg L.

Drugs, Vol. 71, Iss. 1, 2011-01 ,pp. : 101-108

Adis International

Access to resources Recommend Favorite